Change Healthcare (NASDAQ:CHNG) initiated with Outperform rating and $18 (23% upside) price target at Raymond James.
Health Catalyst (NASDAQ:HCAT) initiated with Strong Buy rating and $46 (52% upside) price target at Raymond James.
HealthStream (NASDAQ:HSTM) initiated with Market Perform rating at Raymond James.
Immunomedics (NASDAQ:IMMU) initiated with Buy rating and $26 (30% upside) price target at BofA Global Research.
Marinus Pharmaceuticals (NASDAQ:MRNS) initiated with Outperform rating and $6 (400% upside) price target at Oppenheimer.
Medical Properties Trust (NYSE:MPW) initiated with Buy rating and $25 (23% upside) price target at Mizuho Securities.
Omega Healthcare Investors (NYSE:OHI) initiated with Buy rating and $50 (21% upside) price target at Mizuho.
Phreesia (NYSE:PHR) initiated with Outperform rating and $33 (27% upside) price target at Raymond James.
Physicians Realty Trust (NYSE:DOC) initiated with Buy rating and $20 (7% upside) price target at Mizuho.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.